Secciones
Referencias
Resumen
Servicios
Descargas
HTML
ePub
PDF
Buscar
Fuente


Comment on the study Coronary Artery Bypass Surgery in Brazil: Analysis of the National Reality Through the Bypass Registry that was presented at the 46th Congress of the Brazilian Society of Cardiovascular Surgery, Nova Lima, BH, Brazil, April 5 and 6, 2019
Brazilian Journal of Cardiovascular Surgery, vol. 34, no. 4, pp. 504-506, 2019
Sociedade Brasileira de Cirurgia Cardiovascular

LETTER TO THE EDITOR

This cross-sectional study started in 2015, including 2,292 patients undergoing coronary artery bypass grafting (CABG) and cataloged in the BYPASS registry, aiming to constitute an institutional database on CABG in Brazil. The main objective was to analyze the profile, risk factors, results and surgical strategy employed in these patients.

It is noteworthy the small number of patients included (2,292), which shows little adherence to the registry. In addition, we know that even with a voluntary presentation, more complex patients with very bulky data are more difficult to report. As a comparison term, DATASUS sources show that 226,629 isolated CABG surgeries were performed in a 10-year period in Brazil (Jan 2008 to Feb 2018), with or without cardiopulmonary bypass (CPB).

The results of the study[1] presented by the authors demonstrate well our reality: 42.5% were diabetic and 71% had previous acute myocardial infarction. An important information that I consider excellent, but out of a reality for all the cases performed in Brazil, is that 32.9% of the patients went through the "heart time". Probably the discussion promoted between the clinician and the interventional cardiologist was complemented by the surgeon.

Most CABGs were performed with CPB (87%) and cardioplegic arrest (95.2%), and the mean number of vessels treated was three. Only 6.9% of the operated patients received bilateral internal thoracic grafts, which is in agreement with the international databases, although there is great regional variation.

I consider the observed mortality (2.8%) low, close to that reported by STS (about 2.3%). At InCor-São Paulo, in 2018, 595 patients underwent CABG. The overall mortality was 3.9%, but when only elective and isolated CABG were considered, this percentage fell to 1.9%.

I salute the authors for the importance and relevance of the topic addressed. We know that records like the one proposed allow us to create a database that helps us better understand the difficulties and improve the results.

I leave some questions to Dr. Rodrigo: How do you explain such low mortality? What is the actual adjusted score of these patients (STS, Euroscore) and the evaluation of the data quality in relation to the accuracy? That is, if they are moderate or high-risk patients, better still. Did the mortality occur within 30 days or was in-hospital?

I close once again emphasizing that quality improvement programs in surgical patient care have been positively increasing the results of CABG surgery.

Answer

The BYPASS Registry: Coping with our forthcoming needs

Dear Editor

We thank the comments of Professor Dallan on our paper[1]. Comprehensive national registries on medical procedures are an established necessity, then the reason for existence of the Bypass project.

Much like other similar databases, the beginning was troubled with budget constraints and restrictive participation of dedicated centers. Nonetheless, the project is gaining traction with guidelines from medical societies categorically stating that active participation in national registries or approved surgical database is essential and a condition for delivery of high-quality cardiovascular care in myocardial revascularization and valvular heart disease[2,3]. Additionally, establish a tool for understanding the real figures for the cardiovascular surgery practice in our country and develop strategies for improvements in quality and excellence.

Addressing the pertinent inquiries, the relative low mortality is clearly related to the quality of the selected centers involved so far and perhaps to the individual characteristics of patients referred for this treatment in our mean. A further study to clarify this aspect is in the pipeline. Also, the recently reformed BYPASS’ datasheet for data collection has incorporated the EuroSCORE risk model, which is likely to provide valuable information in stratifying outcomes accordingly.

Of note, the number of patients inserted in the BYPASS database has doubled in the last two years, with the perception by the surgical teams that their data is protected, the possibility of scientific production and the prospects of implementing continuous improvement processes[4].

REFERENCES

Paez RP, Hossne Junior NA, Santo J, Berwanger O, Santos RHN, Kalil RAK, et al. Coronary artery bypass surgery in Brazil: analysis of the national reality through the BYPASS registry. Braz J Cardiovasc Surg. 2019;34(2):142-8. doi:10.21470/1678-9741-2018-0313.

Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40(2):87-165. doi:10.1093/eurheartj/ehy394.

Nishimura RA, O’Gara PT, Bavaria JE, Brindis RG, Carroll JD, Kavinsky CJ, et al. 2019 AATS/ACC/ASE/SCAI/STS expert consensus systems of care document: a proposal to optimize care for patients with valvular heart disease: a joint report of the American association for thoracic surgery, American college of cardiology, American society of echocardiography, society for cardiovascular angiography and interventions, and society of thoracic surgeons. Catheter Cardiovasc Interv. 2019;94(1):3-26. doi:10.1002/ccd.28196.

Gomes WJ, Kalil RA, Jatene FB. Brazilian registry of cardiovascular surgery in adults fully operational. Braz J Cardiovasc Surg. 2016;31(2):II. doi:10.5935/1678-9741.20160040.

Paez RP, Hossne Junior NA, Santo JADE, Berwanger O, Santos RHN, Kalil RAK, et al. Coronary artery bypass surgery in Brazil: analysis of the national reality through the BYPASS registry. Braz J Cardiovasc Surg. 2019;34(2):142-8. doi:10.21470/1678-9741-2018-0313.

Notes

Luís Alberto O. Dallan1, PhD. Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (InCor-HCFMUSP), São Paulo, SP, Brazil.
Rodrigo Pereira Paez, MD; Nelson Américo Hossne Junior, MD, MSc; Walter J. Gomes, MD, MSc, PhD. 1Hospital São Paulo, Escola Paulista de Medicina da Universidade Federal de São Paulo, (EPM – UNIFESP), São Paulo, SP, Brazil.
José Amalth do Espírito Santo, MD; Otavio Berwanger, MD, PhD; Renato Hideo Nakagawa Santos, MD; Alexandre Biasi Cavalcanti, MD, PhD; Juliana Aparecida Borges de Oliveira, RN; 2Instituto de Pesquisa do Hospital do Coração (IP – HCor), São Paulo, SP, Brazil.
Renato Abdala Karam Kalil, MD, MSc, PhD; Clarissa Garcia Rodrigues, RN, MSc, PhD; 3Instituto de Cardiologia do Rio Grande do Sul – Fundação Universitária de Cardiologia, Porto Alegre, RS, Brazil.
Fabio B. Jatene, MD, PhD; 4Cardiovascular Surgery Division, Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (InCor-HCFMUSP), São Paulo, SP, Brazil.
Alexandre Cabral Zilli, MD; Luiz Carlos Bettiati Jr, MD; 5Hospital de Caridade São Vicente de Paulo, Jundiaí, SP, Brazil. 6Instituto de Medicina Integral Professor Fernando Figueira (IMIP), Recife, PE, Brazil.
Fernando Augusto Marinho dos Santos Figueira, MD; Stephanie Steremberg Pires D’Azevedo, RN; 7Hospital de Base – FUNFARME e FAMERP, São José do Rio Preto, SP, Brazil.
Marcelo José Ferreira Soares, MD; Marcio Pimentel Fernandes,MD
Roberto Vito Ardito, MD; Renata Andrea Barberio Bogdan, MD; 8Instituto de Moléstias Cardiovasculares (IMC), São José do Rio Preto, SP, Brazil.
Valquíria Pelisser Campagnucci, MD, MSc, PhD; Diana Nakasako, MD; 9Irmandade da Santa Casa de São Paulo (INCT-HPV/Faculdade de Ciências Médicas da Santa Casa de São Paulo), São Paulo, SP, Brazil
Anilton Bezerra Rodrigues Junior, MD; Marcelo Matos Cascudo, MD; 10Instituto do Coração de Natal, Natal, RN, Brazil.
Fernando Antibas Atik, MD, PhD; Elson Borges Lima, MD; 11Instituto de Cardiologia do Distrito Federal, Brasília, DF, Brazil.
Vinicius José da Silva Nina, MD, PhD; Renato Albuquerque Heluy12; 12Hospital Universitário da Universidade Federal do Maranhão (HU/UFMA), São Luís, MA, Brazil.
Lisandro Gonçalves Azeredo, MD; Odilon Silva Henrique Junior, MD; 13Hospital Evangélico, Cachoeiro de Itapemirim, ES, Brazil.
José Teles de Mendonça, MD, PhD; Katharina Kelly de Oliveira Gama Silva14; 14Hospital do Coração de Sergipe, Aracaju, SE, Brazil. 15Instituto de Cirurgia Cardiovascular (ICCV)/Hospital Nossa Senhora da Salete, Cascavel, PR, Brazil.
Marcelo Pandolfo, MD; José Dantas de Lima Júnior, MD, MSc
Renato Max Faria, MD; Jonas Gonçalves dos Santos, MD; 16Hospital Wilson Rosado, Mossoró, RN, Brazil.
Guilherme Henrique Biachi Coelho, MD; 17Hospital Bosque da Saúde, São Paulo, SP, Brazil.
Sergio Nunes Pereira, MD; Roberta Senger, RN; 18Hospital Universitário de Santa Maria, Santa Maria, RS, Brazil.
Enio Buffolo, MD, PhD; Guido Marco Caputi, MD, PhD; 19Hospital do Coração (HCor), São Paulo, SP, Brazil.
the BYPASS Registry Study Group


Buscar:
Ir a la Página
IR
Scientific article viewer generated from XML JATS4R by